PPAR Research Q2
Unclaimed
PPAR Research is a journal indexed in SJR in Drug Discovery and Pharmacology (medical) with an H index of 59. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1170 €. The scope of the journal is focused on PPAR alpha, PPAR-beta, PPAR delta, PPAR gamma, peroxisome proliferator-activated receptors. It has an SJR impact factor of 0,698 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,698.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1170 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,698
SJR Impact factor59
H Index15
Total Docs (Last Year)69
Total Docs (3 years)877
Total Refs199
Total Cites (3 years)69
Citable Docs (3 years)3.25
Cites/Doc (2 years)58.47
Ref/DocOther journals with similar parameters
Biomolecules and Therapeutics Q2
Current Drug Targets Q2
Journal of Gene Medicine Q2
Current Gene Therapy Q2
Drug Development Research Q2
Compare this journals
Aims and Scope
Best articles by citations
Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
View morePeroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?
View morePeroxisome Proliferator-Activated Receptor- gammain Amyotrophic Lateral Sclerosis and Huntington's Disease
View morePeroxisome Proliferator-Activated Receptor- gammain Thyroid Autoimmunity
View moreThe Roles of PPARs in the Fetal Origins of Metabolic Health and Disease
View morePeroxisome Proliferator-Activated Receptor- gammaPromotes Adipogenic Changes in Growth Plate Chondrocytes In Vitro
View morePeroxisome Proliferator-Activated Receptor- Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer
View morePeroxisome Proliferator-Activated Receptor-aActivation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension
View morePeroxisome Proliferator-Activated Receptord: A Target with a Broad Therapeutic Potential for Drug Discovery
View morePeroxisome Proliferator-Activated Receptors and Acute Lung Injury
View morePeroxisome Proliferator-Activated Receptors as Mediators of Phthalate-Induced Effects in the Male and Female Reproductive Tract: Epidemiological and Experimental Evidence
View moreTargeting PPAR gammaSignaling Cascade for the Prevention and Treatment of Prostate Cancer
View morePeroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
View morePeroxisome Proliferator-Activated Receptors: "Key" Regulators of Neuroinflammation after Traumatic Brain Injury
View moreRole of PPARs in Radiation-Induced Brain Injury
View moreExpression of Concern on "Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARa"
View moreSmad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli Cells
View moreTestosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARa
View moreGene Expression Profiling in Wild-Type and PPAR-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR-Independent Effects
View moreThe Role of PPARs in Placental Immunology: A Systematic Review of the Literature
View moreThe Antifibrosis Effects of Peroxisome Proliferator-Activated Receptordon Rat Corneal Wound Healing after Excimer Laser Keratectomy
View moreActivated PPAR gammaTargets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells
View moreRegulation of Sulfotransferase and UDP-Glucuronosyltransferase Gene Expression by the PPARs
View moreCryptochrome and Period Proteins Are Regulated by the CLOCK/BMAL1 Gene: Crosstalk between the PPARs/RXR-Regulated and CLOCK/BMAL1-Regulated Systems
View more
Comments